Susquehanna International Group, LLP Vbi Vaccines Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$0.29 - $0.64 $2,239 - $4,942	7,722 Added 3.95%	203,295 $60,000
Q4 2022 Feb 14, 2023	SELL	$0.38 - $22.5 $8,928 - $528,660	-23,496 Reduced 10.73%	195,573 $76,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $80,571 - $2.58 Million	-110,372 Reduced 33.5%	219,069 $155,000
Q2 2022 Aug 15, 2022	SELL	$0.66 - $1.81 $56,284 - $154,354	-85,279 Reduced 20.56%	329,441 $266,000
Q1 2022 May 16, 2022	SELL	$1.27 - $2.47 $1.05 Million - $2.05 Million	-829,929 Reduced 66.68%	414,720 $688,000
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $1.25 Million - $1.82 Million	566,650 Added 83.58%	1,244,649 $2.91 Million
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $2.69 Million - $3.58 Million	-962,337 Reduced 58.67%	677,999 $2.11 Million
Q2 2021 Aug 11, 2021	SELL	$2.61 - $4.17 $484,008 - $773,301	-185,444 Reduced 10.16%	1,640,336 $5.5 Million
Q1 2021 May 17, 2021	BUY	$2.91 - $4.32 $1.55 Million - $2.3 Million	532,311 Added 41.15%	1,825,780 $5.68 Million
Q4 2020 Feb 16, 2021	BUY	$2.15 - $3.5 $663,541 - $1.08 Million	308,624 Added 31.34%	1,293,469 $3.56 Million
Q3 2020 Nov 16, 2020	BUY	$2.77 - $6.17 $1.49 Million - $3.32 Million	537,928 Added 120.36%	984,845 $2.82 Million
Q2 2020 Aug 14, 2020	BUY	$0.87 - $3.13 $43,137 - $155,194	49,583 Added 12.48%	446,917 $1.39 Million
Q1 2020 May 15, 2020	BUY	$0.73 - $1.91 $189,216 - $495,073	259,201 Added 187.65%	397,334 $377,000
Q4 2019 Feb 14, 2020	BUY	$0.48 - $1.38 $44,157 - $126,951	91,994 Added 199.38%	138,133 $191,000
Q3 2019 Nov 14, 2019	SELL	$0.47 - $1.05 $1,671 - $3,733	-3,556 Reduced 7.16%	46,139 $22,000
Q2 2019 Aug 16, 2019	BUY	$0.65 - $2.12 $16,697 - $54,458	25,688 Added 107.0%	49,695 $58,000
Q2 2019 Aug 14, 2019	BUY	$0.65 - $2.12 $15,604 - $50,894	24,007 New	24,007 $28,000
Q4 2018 Feb 14, 2019	SELL	$1.22 - $2.41 $16,429 - $32,455	-13,467 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.75 - $2.93 $5,363 - $8,980	-3,065 Reduced 18.54%	13,467 $33,000
Q2 2018 Aug 14, 2018	BUY	$2.75 - $3.85 $45,463 - $63,648	16,532 New	16,532 $45,000

Others Institutions Holding VBIV

# of Institutions

Shares Held

688K

Call Options Held

Put Options Held

Frontier Wealth Management LLC Kansas City, MO

602K
Shares

$12,036
0.01% of portfolio
ETF Managers Group, LLC Summit, NJ

85.7K
Shares

$1,714
0.0% of portfolio

View Full List

About VBI Vaccines Inc

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

More about VBIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account